A. Rossebø

发表

Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.

J. Chambers, I. Holme, C. Nienaber, 2008, The New England journal of medicine.

Impact of hypertension on left ventricular structure in patients with asymptomatic aortic valve stenosis (a SEAS substudy)

E. Staal, A. Rossebø, E. Gerdts, 2010, Journal of hypertension.

3P-0870 Design of the simvastatin and szetimibe in aortic stenosis (SEAS) study

T. Pedersen, A. Rossebø, Y. Mitchel, 2003 .

Observed and predicted reduction of ischemic cardiovascular events in the Simvastatin and Ezetimibe in Aortic Stenosis trial.

I. Holme, K. Egstrup, T. Pedersen, 2010, The American journal of cardiology.

Effect of lipid lowering on new-onset atrial fibrillation in patients with asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study.

L. Køber, C. Nienaber, K. Egstrup, 2012, American heart journal.

Low myocardial energetic efficiency is associated with increased mortality in aortic stenosis

S. Willems, C. Mancusi, A. Rossebø, 2021, Open Heart.

Effect of obesity on left ventricular mass and systolic function in patients with asymptomatic aortic stenosis (a Simvastatin Ezetimibe in Aortic Stenosis [SEAS] substudy).

C. Gohlke-Bärwolf, A. Rossebø, E. Gerdts, 2010, American Journal of Cardiology.

Higher left ventricular mass–wall stress–heart rate product and outcome in aortic valve stenosis

J. Chambers, R. Devereux, A. Rossebø, 2019, Heart.

Is Aortic Bioprosthesis Degeneration Influenced by Metabolic Factors?

A. Rossebø, 2012, Cardiology.

Left atrial size and function as predictors of new-onset of atrial fibrillation in patients with asymptomatic aortic stenosis: the simvastatin and ezetimibe in aortic stenosis study.

L. Køber, M. Dalsgaard, K. Egstrup, 2013, International journal of cardiology.

Factors influencing left ventricular structure and stress-corrected systolic function in men and women with asymptomatic aortic valve stenosis (a SEAS Substudy).

E. Staal, A. Rossebø, E. Gerdts, 2008, The American journal of cardiology.

Stroke in Patients With Aortic Stenosis: The Simvastatin and Ezetimibe in Aortic Stenosis Study

L. Køber, R. Devereux, M. Dalsgaard, 2014, Stroke.

Hyperlipidaemia and aortic valve disease

T. Pedersen, A. Rossebø, 2004, Current opinion in lipidology.

Response to Letters Regarding Article, “Outcome of Patients With Low-Gradient “Severe” Aortic Stenosis and Preserved Ejection Fraction”

F. Neumann, I. Holme, C. Nienaber, 2011 .

Analyses of Cancer Data from Three Ezetimibe Trials

T. Pedersen, A. Rossebø, Y. A. Kesäniemi, 2009 .

Prognostic impact of impaired left ventricular midwall function during progression of aortic stenosis

C. Nienaber, K. Egstrup, A. Rossebø, 2020, Echocardiography.

Hypertension in Aortic Stenosis: Implications for Left Ventricular Structure and Cardiovascular Events

E. Staal, C. Gohlke-Bärwolf, K. Boman, 2012, Hypertension.

Prognosis in asymptomatic patients with discordantly graded aortic valve stenosis based on pressure recovery adjusted valve area

E. Pedersen, A. Rossebø, E. Gerdts, 2022, Open Heart.

Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.

L. Køber, C. Nienaber, K. Egstrup, 2013, International journal of cardiology.

Clinical Implications of Electrocardiographic Left Ventricular Strain and Hypertrophy in Asymptomatic Patients With Aortic Stenosis: The Simvastatin and Ezetimibe in Aortic Stenosis Study

L. Køber, R. Devereux, C. Nienaber, 2012, Circulation.

Risk factors for unexpected sudden death in patients with non-symptomatic aortic stenosis (the SEAS study)

I. Holme, C. Gohlke-Bärwolf, J. Chambers, 2010 .

Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study.

I. Holme, C. Nienaber, T. Skjaerpe, 2007, The American journal of cardiology.

See Clinical Perspective See Editorial by Barasch and Reichek

G. Cioffi, R. Devereux, T. Pedersen, 2022 .

Resting heart rate and risk of adverse cardiovascular outcomes in asymptomatic aortic stenosis: the SEAS study.

P. Okin, L. Køber, R. Devereux, 2015, International journal of cardiology.

Renin-angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis.

L. Køber, R. Devereux, C. Nienaber, 2014, International journal of cardiology.

Usefulness of the electrocardiogram in predicting cardiovascular mortality in asymptomatic adults with aortic stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis Study).

P. Okin, L. Køber, R. Devereux, 2014, The American journal of cardiology.

Antihypertensive Treatment With β‐Blockade in Patients With Asymptomatic Aortic Stenosis and Association With Cardiovascular Events

P. Okin, R. Devereux, C. Nienaber, 2017, Journal of the American Heart Association.

Association of Annual N-Terminal Pro-Brain Natriuretic Peptide Measurements With Clinical Events in Patients With Asymptomatic Nonsevere Aortic Stenosis: A Post Hoc Substudy of the SEAS Trial.

C. Nienaber, M. Olsen, O. Nielsen, 2022, JAMA cardiology.

Indexing aortic valve area by body surface area increases the prevalence of severe aortic stenosis

J. Chambers, F. Neumann, C. Nienaber, 2013, Heart.

Outcome of Patients With Low-Gradient “Severe” Aortic Stenosis and Preserved Ejection Fraction

J. Chambers, F. Neumann, I. Holme, 2011, Circulation.

Impact of baseline severity of aortic valve stenosis on effect of intensive lipid lowering therapy (from the SEAS study).

J. Chambers, I. Holme, C. Nienaber, 2010, The American journal of cardiology.

Impact of QRS duration and morphology on the risk of sudden cardiac death in asymptomatic patients with aortic stenosis: the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study.

L. Køber, R. Devereux, K. Boman, 2012, Journal of the American College of Cardiology.

Impact of stroke volume on cardiovascular risk during progression of aortic valve stenosis

G. de Simone, C. Gohlke-Bärwolf, K. Boman, 2017, Heart.

Left Atrial Systolic Force and Outcome in Asymptomatic Mild to Moderate Aortic Stenosis

G. Cioffi, G. de Simone, M. Dalsgaard, 2012, Echocardiography.

Left ventricular systolic and diastolic function in asymptomatic patients with moderate aortic stenosis.

T. Pedersen, K. Steine, A. Rossebø, 2008, The American journal of cardiology.

Sudden cardiac death in asymptomatic patients with aortic stenosis

J. Chambers, F. Neumann, A. Rossebø, 2020, Heart.

Effect of Randomized Lipid Lowering With Simvastatin and Ezetimibe on Cataract Development (from the Simvastatin and Ezetimibe in Aortic Stenosis Study).

P. Okin, R. Devereux, C. Gohlke-Bärwolf, 2015, The American journal of cardiology.

A risk score for predicting mortality in patients with asymptomatic mild to moderate aortic stenosis

Terje R Pedersen, Kenneth Egstrup, William Malbecq, 2011, Heart.

Lipid Lowering Treatment in Mild to Moderate Aortic Stenosis

A. Rossebø, 2016 .

Association of high-sensitivity troponin T with outcomes in asymptomatic non-severe aortic stenosis: a post-hoc substudy of the SEAS trial

C. Nienaber, M. Olsen, O. Nielsen, 2023, EClinicalMedicine.

, Kurt Study Stroke in Patients With Aortic Stenosis : The Simvastatin and Ezetimibe in Aortic Stenosis

L. Køber, R. Devereux, M. Dalsgaard, 2022 .

Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.

J. Chambers, I. Holme, C. Nienaber, 2008, The New England journal of medicine.

See Clinical Perspective See Editorial by Barasch and Reichek

T. Pedersen, A. Rossebø, E. Gerdts, 2022 .

Gender Differences in Cardiac Organ Damage in Arterial Hypertension: Assessing the Role of Drug Nonadherence

A. Rossebø, E. Gerdts, Assami Rösner, 2024, High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension.